Health Minister announces a $7 million grant to Magellan Stem Cells

Last night on 10 News First (see the news report here), the Australian Government’s Health Minister The Hon Mark Butler announced a $7 million grant to Magellan Stem Cells to help deliver a Phase III human trial for our donor stem cell treatment for osteoarthritis.

The minister said: “Osteoarthritis is a huge cause of pain and disability in Australia.”

There are about 2.2 million sufferers, costing the Australian economy more than $A25 billion annually.

“Up until now the treatments only extended to pain relief and potentially replacement surgery, like knee replacements,” the minister said.

Patient Keryn Hutchison told 10 News how the treatment “gave me my life back”.

The trial is due to start next year.

 

Magellan are pleased to announce the results of our Phase 1/2 allogenic trial. The research findings are published in Osteoarthritis and Cartilage Open the open-access journal of Osteoarthritis Research Society International (OARSI), which publishes the evidence-based, international consensus guidelines on osteoarthritis management.  

Australian Health Minister announced a $7 million grant to Magellan Stem Cells – read more here

Should you want further information regarding our results or media release please email info@magellanstemcells.com.au or call 03 9270 8080.

Investment Enquiry

Download the full Investor Presentation